HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Biocept, Inc. (BIOC)
0.6565  -0.0361  (-5.21%) 07-03 15:26
Open: 0.685 High: 0.6929
Pre.close: 0.6926 Low: 0.6401
Volume: 10,473,772 Ave vol: 27,160,693
52w High: 1.15 52w Low: 0.21
MA(50): 0.568 MA(200): 0.402
EPS: -0.736 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://biocept.com
Market Cap (M): 86
Shares Out (M): 131
Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreaticobiliary cancer, and ovarian cancer. The company's Target-Selector molecular technology enables detection of mutations and genome alterations with enhanced sensitivity and specificity, as well as is applicable to nucleic acid from ctDNA.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 1.14 Target 2: 1.34
Resist 1: 0.98 Resist 2: 1.14
Support 1: 0.63 Support 2: 0.41
Company key metrics
Revenue per Share: 0.2676
Net Income per Share: -1.2167
Cash per Share: 0.4502
Book Value per Share: 0.5421
Price to Sales: 1.1585
Price to Book Value: 0.5718
Earnings Yield: -3.9248
Dividend Yield: 0
Debt to Equity: 0.5832
Debt to Assets: 0.3684
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 30 Jun 2020
Biocept Awarded Canadian Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells, from a Biological Fluid Sample such as Blood or Cerebrospinal Fluid - PRNewswire

Fri, 05 Jun 2020
Biocept to Relocate Corporate Offices and CLIA-Certified Laboratory to New San Diego Location - PRNewswire

Tue, 30 Jun 2020
Biocept, Inc. (BIOC) future in Healthcare Sector - The News Heater

Mon, 22 Jun 2020
Biocept Announces the Availability of 10,000 Specimen Collection Kits for RT-PCR COVID-19 Testing - PRNewswire

Tue, 16 Jun 2020
Biocept Inc (BIOC) Down -7.36%; Slightly Overvalued but Growing Rapidly - InvestorsObserver

Mon, 29 Jun 2020
Biocept to provide coronavirus test kits, will cover out-of-network patients for liquid biopsy tests - Proactive Investors USA & Canada

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.